Allotransplantation - Wikipedia
Allotransplant (allo- meaning "other" in Greek) is the transplantation of cells, tissues, or organs to a recipient from a genetically non-identical donor of the same species. [1] . The transplant is called an allograft, allogeneic transplant, or homograft. Most …
Allotransplantation - Latest research and news | Nature
Allotransplantation is the transplantation of an organ or tissue from one individual to another of the same species with a different genotype. The transplant is called an allograft.
Living Bone Allotransplants Survive by Surgical Angiogenesis …
This study demonstrates a novel method of composite-tissue allotransplantation, permitting long-term drug-free survival, with use of therapeutic angiogenesis of autogenous vessels to maintain circulation.
Allogeneic transplantation for advanced acute leukemia
2022年12月9日 · Outcomes of allogeneic hematopoietic cell transplantation (HCT) for patients with advanced acute leukemia and myelodysplastic syndromes (MDS) remain uncertain. All published series include the important and often not stated selection bias that influences outcome.
Recent advances in our understanding of the allograft response
Allotransplantation saves and improves many thousands of lives every year and is the most common treatment for end-stage lung, heart, liver and kidney disease. The global demand continues to rise, yet there are unresolved challenges to this therapy.
Allotransplantation - an overview | ScienceDirect Topics
Allotransplantation is the gold standard treatment for end-stage organ failure. However, this life-saving treatment is limited by the challenge of controlling the immune system to prevent damage to the foreign organ.
Composite tissue allotransplantation: opportunities and …
2019年3月6日 · In this review article, we provide a comprehensive update on limb and face transplantation, with a specific emphasis on the alloimmune responses to VCA, established and novel immunosuppressive...
Allotransplantation - an overview | ScienceDirect Topics
2013年8月15日 · Allotransplantation is the most common treatment for end stage kidney, liver, lung, and heart disease. In order to accommodate the allograft, the recipient must be immune-suppressed, to prevent rejection of the graft by the innate and adaptive immune system.
A Comprehensive Guide to Allotransplantation - Medical …
Allotransplantation is a life-saving procedure that involves transplanting organs and tissues between genetically non-identical individuals. Understanding the types, risks, advances, and ethical considerations is crucial for improving outcomes and supporting the transplant community.
Cellular Therapies in Solid Organ Allotransplantation: Promise …
In this review, we focus on the variety of cellular therapies that have been applied in human trials and non-human primate models, describe their efficacy, highlight data regarding their potential for sensitization, and discuss opportunities for cellular therapies within our current understanding of the immune landscape.
- 某些结果已被删除